These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 11907208)

  • 21. Inhibition of hepatitis C virus (HCV) RNA polymerase by DNA aptamers: mechanism of inhibition of in vitro RNA synthesis and effect on HCV-infected cells.
    Bellecave P; Cazenave C; Rumi J; Staedel C; Cosnefroy O; Andreola ML; Ventura M; Tarrago-Litvak L; Astier-Gin T
    Antimicrob Agents Chemother; 2008 Jun; 52(6):2097-110. PubMed ID: 18347106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selection of 3'-template bases and initiating nucleotides by hepatitis C virus NS5B RNA-dependent RNA polymerase.
    Shim JH; Larson G; Wu JZ; Hong Z
    J Virol; 2002 Jul; 76(14):7030-9. PubMed ID: 12072503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NMR reveals the intrinsically disordered domain 2 of NS5A protein as an allosteric regulator of the hepatitis C virus RNA polymerase NS5B.
    Bessa LM; Launay H; Dujardin M; Cantrelle FX; Lippens G; Landrieu I; Schneider R; Hanoulle X
    J Biol Chem; 2017 Nov; 292(44):18024-18043. PubMed ID: 28912275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of hepatitis C virus (HCV) replication by specific RNA aptamers against HCV NS5B RNA replicase.
    Lee CH; Lee YJ; Kim JH; Lim JH; Kim JH; Han W; Lee SH; Noh GJ; Lee SW
    J Virol; 2013 Jun; 87(12):7064-74. PubMed ID: 23596299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of monoclonal antibodies that specifically recognize the palm subdomain of hepatitis C virus nonstructural protein 5B polymerase.
    Ingravallo P; Lahser F; Xia E; Sodowich B; Lai VC; Hong Z; Zhong W
    Virus Res; 2001 Jun; 75(2):179-87. PubMed ID: 11325472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oligomerization and cooperative RNA synthesis activity of hepatitis C virus RNA-dependent RNA polymerase.
    Wang QM; Hockman MA; Staschke K; Johnson RB; Case KA; Lu J; Parsons S; Zhang F; Rathnachalam R; Kirkegaard K; Colacino JM
    J Virol; 2002 Apr; 76(8):3865-72. PubMed ID: 11907226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a C-terminal regulatory motif in hepatitis C virus RNA-dependent RNA polymerase: structural and biochemical analysis.
    Lévêque VJ; Johnson RB; Parsons S; Ren J; Xie C; Zhang F; Wang QM
    J Virol; 2003 Aug; 77(16):9020-8. PubMed ID: 12885918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation and characterization of RNA aptamers specific for the HCV minus-IRES domain I.
    Konno K; Fujita S; Iizuka M; Nishikawa S; Hasegawa T; Fukuda K
    Nucleic Acids Symp Ser (Oxf); 2008; (52):493-4. PubMed ID: 18776469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selection of RNA aptamers that bind specifically to the NS3 protease of hepatitis C virus.
    Urvil PT; Kakiuchi N; Zhou DM; Shimotohno K; Kumar PK; Nishikawa S
    Eur J Biochem; 1997 Aug; 248(1):130-8. PubMed ID: 9310370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation and characterization of RNA aptamers specific for the hepatitis C virus nonstructural protein 3 protease.
    Fukuda K; Vishnuvardhan D; Sekiya S; Hwang J; Kakiuchi N; Taira K; Shimotohno K; Kumar PK; Nishikawa S
    Eur J Biochem; 2000 Jun; 267(12):3685-94. PubMed ID: 10848986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thumb inhibitor binding eliminates functionally important dynamics in the hepatitis C virus RNA polymerase.
    Davis BC; Thorpe IF
    Proteins; 2013 Jan; 81(1):40-52. PubMed ID: 22855387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of activity and inhibition of the hepatitis C virus RNA-dependent RNA polymerase.
    Reich S; Golbik RP; Geissler R; Lilie H; Behrens SE
    J Biol Chem; 2010 Apr; 285(18):13685-93. PubMed ID: 20194503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A cell-based assay for RNA synthesis by the HCV polymerase reveals new insights on mechanism of polymerase inhibitors and modulation by NS5A.
    Ranjith-Kumar CT; Wen Y; Baxter N; Bhardwaj K; Cheng Kao C
    PLoS One; 2011; 6(7):e22575. PubMed ID: 21799903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rate-limiting pyrophosphate release by hepatitis C virus polymerase NS5B improves fidelity.
    Villalba B; Johnson KA
    J Biol Chem; 2020 Nov; 295(48):16436-16444. PubMed ID: 32938715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RNA-dependent RNA polymerase activity encoded by GB virus-B non-structural protein 5B.
    Zhong W; Ingravallo P; Wright-Minogue J; Uss AS; Skelton A; Ferrari E; Lau JY; Hong Z
    J Viral Hepat; 2000 Sep; 7(5):335-42. PubMed ID: 10971821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of soluble hepatitis C virus RNA-dependent RNA polymerase expressed in Escherichia coli.
    Ferrari E; Wright-Minogue J; Fang JW; Baroudy BM; Lau JY; Hong Z
    J Virol; 1999 Feb; 73(2):1649-54. PubMed ID: 9882374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutagenesis analysis of the rGTP-specific binding site of hepatitis C virus RNA-dependent RNA polymerase.
    Cai Z; Yi M; Zhang C; Luo G
    J Virol; 2005 Sep; 79(18):11607-17. PubMed ID: 16140738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of constrained peptides that bind to and preferentially inhibit the activity of the hepatitis C viral RNA-dependent RNA polymerase.
    Amin A; Zaccardi J; Mullen S; Olland S; Orlowski M; Feld B; Labonte P; Mak P
    Virology; 2003 Aug; 313(1):158-69. PubMed ID: 12951030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein kinase C-related kinase 2 regulates hepatitis C virus RNA polymerase function by phosphorylation.
    Kim SJ; Kim JH; Kim YG; Lim HS; Oh JW
    J Biol Chem; 2004 Nov; 279(48):50031-41. PubMed ID: 15364941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of interactions between hepatitis C virus NS5B polymerase, annexin A2 and RNA - effects on NS5B catalysis and allosteric inhibition.
    Solbak SMØ; Abdurakhmanov E; Vedeler A; Danielson UH
    Virol J; 2017 Dec; 14(1):236. PubMed ID: 29228983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.